Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Study of LY900014 Compared to Insulin Lispro in Participants With Type 2 Diabetes

ClinicalTrials.gov ID: NCT03214380

Public ClinicalTrials.gov record NCT03214380. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 14, 2026, 8:35 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Prospective, Randomized, Double-Blind Comparison of LY900014 to Insulin Lispro, Both in Combination With Insulin Glargine or Insulin Degludec in Adults With Type 2 Diabetes PRONTO-T2D

Study identification

NCT ID
NCT03214380
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Eli Lilly and Company
Industry
Enrollment
933 participants

Conditions and interventions

Interventions

  • Insulin Degludec Drug
  • Insulin Glargine Drug
  • Insulin Lispro Drug
  • LY900014 Drug
  • Metformin Drug
  • SGLT2 inhibitor Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 13, 2017
Primary completion
Aug 13, 2018
Completion
Mar 12, 2019
Last update posted
Mar 26, 2020

2017 – 2019

United States locations

U.S. sites
32
U.S. states
14
U.S. cities
29
Facility City State ZIP Site status
Valley Research Fresno California 93720
Diabetes and Endocrine Associates La Mesa California 91942
First Valley Medical Group Lancaster California 93534
National Research Institute Los Angeles California 90057
Care Access Research Santa Clarita California 91321
Encompass Clinical Research Spring Valley California 91978
University Clinical Investigators, Inc. Tustin California 92780
ALL Medical Research, LLC Cooper City Florida 33024
The Center For Diabetes & Endocrine Care Fort Lauderdale Florida 33312
East Coast Institute For Research Jacksonville Florida 32216
Sun Coast Clinical Research, Inc New Port Richey Florida 34652
East West Medical Institute Honolulu Hawaii 96814
Elite Clinical Trials LLLP Blackfoot Idaho 83221
Northwest Clinical Trials Boise Idaho 83704
Rocky Mountain Diabetes and Osteoporosis Center Idaho Falls Idaho 83404
Prairie Education and Research Cooperative Springfield Illinois 62711
Iderc, P.L.C. West Des Moines Iowa 50265
University of Kansas Medical Center Kansas City Kansas 66160
Cotton O'Neil Diabetes and Endocrinology Center Kansas City Kansas 66606
Palm Research Center Las Vegas Nevada 89128
Palm Research Center Las Vegas Nevada 89148
Manhattan Medical Research New York New York 10016
Aventiv Research Columbus Ohio 43213
Heritage Valley Medical Group, Inc. Beaver Pennsylvania 15009
Partners in Nephrology & Endocrinology Pittsburgh Pennsylvania 15224
Texas Diabetes and Endocrinology Austin Texas 78731-4309
Texas Diabetes and Endocrinology-Austin South Austin Texas 78749
Dallas Diabetes Endocrine Center Dallas Texas 75230
Consano Clinical Research Shavano Park Texas 78231
Progressive Clinical Research Bountiful Utah 84010
Private: Dr. Larry Stonesifer Federal Way Washington 98003
Rainier Clinical Research Center Renton Washington 98057

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 109 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03214380, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 26, 2020 · Synced May 14, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03214380 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →